Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
NCT07550985

Routine Probe Compression After Transrectal Prostate Biopsy(RPCAB) to Reduce Bleeding and Infectious Complications : A Randomized Controlled Trial

Led by Veterans Health Service Medical Center, Seoul, Korea · Updated on 2026-04-24

324

Participants Needed

1

Research Sites

47 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Hematuria (up to 50%) and rectal bleeding (up to 30%) are common complications following transrectal ultrasound-guided prostate biopsy. Although most cases are mild, some require additional intervention. Short-duration compression has been shown to achieve hemostasis in cases of post-biopsy bleeding, suggesting that routine probe compression may reduce bleeding complications. Post-biopsy bleeding may also be associated with an increased risk of subsequent infection. This randomized controlled trial aims to evaluate the effect of routine probe compression and compression duration after transrectal prostate biopsy on bleeding and infectious complications.

CONDITIONS

Official Title

Routine Probe Compression After Transrectal Prostate Biopsy(RPCAB) to Reduce Bleeding and Infectious Complications : A Randomized Controlled Trial

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male patients aged 18 years or older
  • Scheduled to undergo transrectal ultrasound-guided prostate biopsy
  • First-time prostate biopsy (biopsy-nafve patients)
  • Able to provide written informed consent
Not Eligible

You will not qualify if you...

  • Uncorrectable coagulopathy or bleeding disorder
  • Active urinary tract infection at the time of biopsy
  • Acute anorectal conditions such as hemorrhoidal bleeding, anal fissure, or proctitis
  • Inability to discontinue or manage anticoagulant or antiplatelet therapy appropriately
  • History of severe drug allergy or hypersensitivity to study medications
  • Unable to provide informed consent due to cognitive impairment or medical incapacity
  • Participation in another prostate disease study that may affect this trial's outcomes
  • Severe comorbid conditions limiting participation
  • Unable to comply with follow-up procedures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

VHS medical center

Seoul, Seoul, South Korea, 05368

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here